12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga·02/20/2026 21:05:55

Listen to the news

Gainers

Allarity Therapeutics (NASDAQ:ALLR) shares moved upwards by 7.4% to $0.99 during Friday's after-market session. The market value of their outstanding shares is at $16.8 million.
Acumen Pharmaceuticals (NASDAQ:ABOS) shares rose 7.0% to $2.75. The market value of their outstanding shares is at $164.7 million.
VivoSim Labs (NASDAQ:VIVS) stock moved upwards by 6.43% to $2.15. The market value of their outstanding shares is at $5.1 million.
Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 5.9% to $3.05. The market value of their outstanding shares is at $4.0 million.
Akari Therapeutics (NASDAQ:AKTX) shares rose 5.66% to $0.25. The company's market cap stands at $8.4 million.
Iterum Therapeutics (NASDAQ:ITRM) shares rose 5.18% to $0.22. The market value of their outstanding shares is at $11.6 million.

Losers

Impact BioMedical (AMEX:IBO) stock declined by 6.8% to $0.41 during Friday's after-market session. The company's market cap stands at $5.0 million.
INVO Fertility (NASDAQ:IVF) shares fell 5.27% to $0.94. The company's market cap stands at $14.4 million.
CDT Equity (NASDAQ:CDT) stock fell 3.97% to $0.72. The company's market cap stands at $2.1 million.
Baird Medical Investment (NASDAQ:BDMD) shares declined by 3.84% to $1.49. The company's market cap stands at $56.9 million.
Inhibikase Therapeutics (NASDAQ:IKT) shares declined by 3.41% to $1.7. The company's market cap stands at $211.0 million.
Prelude Therapeutics (NASDAQ:PRLD) shares decreased by 3.24% to $2.69. The company's market cap stands at $142.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English